Saturday, April 17, 2010
Note: no date on this website page
Note: this is timely
Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study
CONCLUSIONS: The results of this Phase I study showed for the first time, to our knowledge, the clinical feasibility of intensity-modulated whole abdominal radiotherapy, which could offer a new therapeutic option for consolidation treatment of advanced ovarian carcinoma after adjuvant chemotherapy in selected subgroups of patients. We initiated a Phase II study to further evaluate the toxicity of this intensive multimodal treatment.
55 minute video: Breakfast with the Chiefs Andre Picard/The Globe and Mail :“What Do Patients Want? A Critical Look at Health Care Delivery in Canada.”
includes discussion on Patient Safety (group)/patient centered groups
Abstract and full free text available: Pelvic mass associated with raised CA 125 for benign condition: A case report
Note: this paper also discusses differences between ultrasound/CT/MRI
Raised CA 125 with associated pelvic mass is highly suggestive of ovarian malignancy, but there are various other benign conditions that can be associated with pelvic mass and a raised CA 125.
We present a case of 19 year old
Note: ovarian cancer patients were not included in this study
Conclusion: This survey suggests that a substantial proportion of patients and their families experience considerable distress associated with the cost of cancer care delivery. Furthermore, these costs affect the decision of patients with cancer to receive recommended treatment. This is a particularly serious issue for individuals with a modest annual income.
Note: as of the timing of this post, these articles are freely available
Early Release Articles *NEW*
1) Timing Is Everything Zon
2) Challenges to National Cancer Institute–Supported Cooperative Group Clinical Trial Participation: An ASCO Survey of Cooperative Group Sites Baer et al
Multidisciplinary Cancer Conferences: Exploring Obstacles and Facilitators to Their Implementation -- Journal of Oncology Practice
Conclusion: Variation exists in the enthusiasm of health professionals and the administrative capacity of institutions regarding routine implementation of MCCs. A systematic implementation plan for MCCs is needed involving both cancer care providers and administrators.
Note: This article was brought to my (and others) attention. It's not about ovarian cancer but liver cancer - excellent reading with many common thoughts ?? Your views?